Monthly Archives: January 2013

Biotech M&A in 2012: The Good, Bad, and Ugly
January 30, 2013

The numbers are in on the 2012 Pharma/Biotech M&A performance, at least according to our friends at HBM Partners.  They’ve released another well-annotated deal report and database. The quick summary from a venture-backed biotech perspective: it was a good year


Early Stage Biotech Showing Positive Signs of Scaling Its Wall of Worry
January 15, 2013

As 2013 begins, and the JPM conference is behind us, it’s a great time to reflect on the state of the biotech industry and the sentiments around early stage investing in particular.  While pessimism abounds in many corners about the


JPM Takeaway: Pharma Wants to Engage Earlier & More Actively
January 11, 2013

Most of the news flow around the JPM Healthcare conferences centers around the main event: public companies presenting their earnings forecasts, R&D updates, new partnering deals, and the like.  There’s also a small private company track at JPM, and there are